ATAK

Welcome to the Brand page for “ATAK”, which is offered here for Biological, medicinal and pharmaceutical preparations and substances for the prevention and treatment of oncological and immune system related diseases and disorders, and for use with transplantation; biological, medicinal and pharmaceutical preparations and substances for the prevention and treatment of cancer and infectious diseases; anti-cancer preparations;medical services for the prevention and treatment of cancer and autoimmune and infectious diseases; medical services for transplantation; medical services and providing information in the fields of cancer, oncology, autoimmune and infectious diseases, and transplantation;providing medical and scientific research information in the fields of cancer, oncology, autoimmune and infectious diseases, and transplantation; medical and scientific research services in the fields of the prevention and treatment of cancer, oncology, autoimmune and infectious diseases, and transplantation; providing laboratory research services in the fields of cancer biology, cancer, oncology, autoimmune and infectious diseases, and transplantation;.

Its status is currently believed to be active. Its class is unavailable. “ATAK” is believed to be currently owned by “Myeloid Therapeutics, Inc.”